Latest Announcements

Genesys International Corporation Ltd has announced a Board Meeting scheduled for June 26, 2026. The primary agenda for this meeting is to consider and evaluate a proposal for raising funds through the issuance of securities, as may be permitted under applicable law. This strategic move suggests potential future growth initiatives or strengthening of the company's financial position. Additionally, the trading window for designated persons and their relatives has been closed from June 23, 2026, until 48 hours after the conclusion of the board meeting.

Sharika Enterprises Ltd. has announced plans to raise funds aggregating approximately Rs. 27.20 Crores through a preferential issue. This includes issuing up to 1,51,49,079 equity shares at Rs. 14.33 each to non-promoter investors (Rs. 21.70 Crores) and up to 38,38,102 convertible warrants at Rs. 14.33 each to promoter and non-promoter investors (Rs. 5.50 Crores). The proposal is subject to approval from shareholders at an Extra Ordinary General Meeting scheduled for July 17, 2026.

Sharika Enterprises Ltd. announced its Board's approval for a preferential issue of up to 1,51,49,079 equity shares to certain non-promoter investors and up to 38,38,102 convertible warrants to promoter and non-promoter investors. The total fundraise, priced at Rs. 14.33 per share/warrant, aggregates approximately Rs. 27.21 Crores. The company will convene an Extra Ordinary General Meeting on July 17, 2026, to seek shareholder approval for these issues, which aim to raise capital in compliance with SEBI ICDR Regulations.

Sharika Enterprises Ltd's Board approved raising approximately Rs. 27.21 crore through a preferential issue. This comprises issuing 1,51,49,079 equity shares at Rs. 14.33 each to non-promoter investors, aggregating Rs. 21.71 crore. Additionally, 38,38,102 convertible warrants, also priced at Rs. 14.33 each, will be issued to both promoter and non-promoter investors, raising Rs. 5.50 crore. The fundraise is contingent upon obtaining necessary regulatory and shareholder approvals at an Extra Ordinary General Meeting scheduled for July 17, 2026.

Sharika Enterprises Ltd's Board approved raising funds up to Rs. 21.71 crore by issuing 1.51 crore equity shares on a preferential basis to non-promoter investors at Rs. 14.33 per share. Additionally, the Board approved raising up to Rs. 5.50 crore through a preferential issue of 38.38 lakh share warrants, convertible into equity shares, to promoter and non-promoter investors at the same price. Both proposals are subject to regulatory approvals and shareholder consent at an Extraordinary General Meeting scheduled for July 17, 2026.

Tanfac Industries Ltd's Fund-Raising Committee has approved the preliminary placement document and authorized the opening of an issue on June 23, 2026. The floor price for the equity shares has been set at ₹ 2090.34, in compliance with SEBI ICDR Regulations. The company retains the option to offer a discount of up to 5% on this floor price, with the final issue price to be determined in consultation with book running lead managers. This marks the initiation of an equity fundraise.

Parmax Pharma Ltd has issued a corrigendum to its Extraordinary General Meeting (EGM) notice dated June 8, 2026, which was called for a preferential issue of equity shares and convertible warrants. The corrigendum corrects the proposed status of Ms. Sheetal Hiren Doshi in the warrant allottees table from 'Promoter*' to 'Promoter Group*'. Additionally, a hyperlink for the Practicing Company Secretary’s Certificate in the explanatory statement has been rectified. All other items of the EGM Notice remain unchanged, with the EGM scheduled for July 2, 2026.

Aster DM Healthcare Ltd's subsidiary, Aster DM Super-Specialty Hospital (Sarjapur) Private Limited, has allotted 12 lakh fully paid-up Series A Compulsorily Convertible Preference Shares (CCPS) and 34.30 lakh partly paid-up Series B CCPS to identified investors on a preferential basis. Each CCPS is convertible into up to 5 equity shares. The Sarjapur entity plans to raise further capital, and Aster DM Healthcare's shareholding will remain above 75% on an as-if converted basis, even after additional investments.

Jattashankar Industries Ltd has approved the preferential allotment of 30,00,000 convertible warrants at an issue price of Rs. 92 per warrant. These warrants, allotted to both promoter and non-promoter categories, are convertible into one equity share each within 18 months. The company has received an initial 25% payment of Rs. 6.90 crores, with a potential total fundraise of Rs. 27.60 crores upon full conversion, aimed at bolstering its financial position and supporting growth initiatives.

Khadim India Ltd announced a Board Meeting on July 2, 2026, to consider a fundraise through a preferential issue of equity shares and/or convertible warrants. The board will also propose an Extra-ordinary General Meeting to secure shareholder approval for this capital raise. Concurrently, the trading window for the company's securities is closed from June 24, 2026, until 48 hours post the declaration of its unaudited standalone and consolidated financial results for the quarter ending June 30, 2026. This move signals a potential capital infusion to support future operations or expansion.

Khadim India Ltd has announced a Board Meeting on July 2, 2026, to consider and approve a fundraising proposal. The company intends to raise capital through a preferential issue of equity shares and/or convertible warrants. An Extra-ordinary General Meeting will be convened to seek shareholders' approval for this proposal. Additionally, the trading window for the company's securities will remain closed from June 24, 2026, until 48 hours after the declaration of the Q1 FY27 financial results.

Power Grid Corporation of India Ltd has scheduled a Board Meeting on June 26, 2026, to consider and approve raising foreign currency funds up to USD 500 million through External Commercial Borrowings (ECB) from domestic or foreign banks. This fundraise is intended to support the company's capital expenditure requirements. The trading window for the company's shares remains closed until 48 hours after the declaration of its Q1 FY2027 financial results.

Apollo Micro Systems Ltd has allotted 21,43,095 equity shares of Re. 1/- each to three investors, including Trikaya Wealth Advisors Pvt Ltd, upon conversion of an equal number of warrants. This conversion, part of a preferential issue intimated earlier, brought in Rs. 18.32 crores (being the balance 75% of the issue price) for the company as warrant exercise price. Consequently, the company's issued and paid-up capital increased to Rs. 37,15,99,512, with the newly allotted shares ranking pari passu with existing ones.

City Union Bank's Board of Directors has approved raising Rs. 500 crore through a Qualified Institutional Placement (QIP) route, pending shareholder approval at the Annual General Meeting on August 14, 2026. Additionally, the bank declared a dividend of 200% (Rs. 2 per equity share) for FY 2026, with a record date set for July 14, 2026. The dividend payment is scheduled to occur on or after the AGM date.

Minolta Finance Ltd has withdrawn the record date of June 30, 2026, for its proposed rights issue. The company cited unforeseen circumstances and pending procedural formalities with the depositories as reasons for the withdrawal. The previously fixed record date now stands cancelled, and the company will separately announce a revised record date and other terms for the rights issue in due course.

City Union Bank's Board approved a 200% dividend (Rs. 2 per share) for FY2026, with a record date of July 14, 2026, to be paid on or after August 14, 2026. Concurrently, the board proposed an enabling resolution for raising Rs. 500 crore through a Qualified Institutional Placement (QIP). This capital raise is subject to shareholder approval at the upcoming Annual General Meeting and is expected to support the bank's future growth initiatives.

Regency Fincorp Ltd announced that it has received approval from BSE Limited for the listing of its privately placed Non-Convertible Debentures (NCDs). These NCDs will be listed on the Debt Market Segment of the exchange, as confirmed by BSE's Notice No. 20260623-19 dated June 23, 2026. This approval is a procedural step that facilitates the secondary market trading of the company's debt instruments.

Minolta Finance Ltd has scheduled a board meeting for June 27, 2026, to consider and approve a proposed Rights Issue. The agenda includes critical aspects such as the revision of equity share pricing, terms of payment, rights entitlement ratio, and record date, along with the issue's opening and closing dates. The board will also discuss regulatory filings and final documentation like the Letter of Offer and application forms, signaling a significant capital-raising initiative for the company.

Rose Merc Ltd announced the grant of 20,000 stock options to three eligible employees under its "RML Employee Stock Option Plan II, 2023". Each option converts into one equity share of Rs. 10 face value, with an exercise price of Rs. 70 per option. The options will vest after one year from the grant date and can be exercised over a four-year period thereafter. This grant is in terms of SEBI (SBEBSE) Regulations, 2021, and aims to incentivize and retain key talent.

Aanchal Ispat Ltd's Board has approved raising funds up to Rs. 8.65 crore by issuing 10.55 lakh fully convertible warrants on a preferential basis to the promoter category. Each warrant is priced at Rs. 82 and will be convertible into one equity share within 18 months. An amount equivalent to 25% of the warrant issue price is payable upfront. This fundraise is subject to shareholder approval and is being done in compliance with the Companies Act and SEBI ICDR Regulations.